The National Health Service (Primary Medical Services Section 17C Agreements) (Scotland) Regulations 2018

JurisdictionScotland
CitationSSI 2018/67
Year2018
(1) These Regulations may be cited as the National Health Service (Primary Medical Services Section 17C Agreements) (Scotland) Regulations 2018.(2) (3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
  • to which the
  • which is entered into between a provider and the Health Board on or after 1st April 2018.
  • (1) In these Regulations—
    • “the Act” means the National Health Service (Scotland) Act 1978;
    • ...
    • “the 2004 Act” means the Primary Medical Services (Scotland) Act 2004;
    • “the 2004 Regulations” means the National Health Service (Primary Medical Services Section 17C Agreements) (Scotland) Regulations 2004;
    • “additional services” means one or more of—
      • (a) cervical screening services;
      • (b) contraceptive services;
      • (c) ...
      • (d) ...
      • (e) child health surveillance services; and
      • (f) maternity medical services;
    • “adjudicator” means the Scottish Ministers or a panel of 3 persons appointed by the Scottish Ministers (as the case may be) under paragraph 58 of schedule 1;
    • “advanced electronic signature” means an advanced electronic signature within the meaning given in Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council of 23 July 2014 on electronic identification and trust services for electronic transactions in the internal market and repealing Directive 1999/93/EC;
    • “agreement” means, unless the context otherwise requires, an agreement under section 17C of the Act
    • (personal medical or dental services) under which primary medical services are provided;
    • “appliance” means an appliance which is included in a list for the time being approved by the Scottish Ministers for the purposes of section 27(1) of the Act
    • ;
    • “area medical committee” means the committee of that name recognised under section 9
    • of the Act (local consultative committees) in the area of the Health Board;
    • “area pharmaceutical committee” means the committee of that name recognised under section 9 of the Act (local consultative committees) in the area of the Health Board;
    • “assessment panel” means a committee or sub-committee of a Health Board (“the first Health Board”) (other than the Health Board (“the second Health Board”) which is a party or a prospective party to the agreement in question) appointed by the first Health Board at the request of the second Health Board to exercise functions under paragraphs 21, 25 or 29 of schedule 2 and which must consist of—
      • (a) the Chief Executive of the first Health Board or an Executive Director of that Health Board nominated by that Chief Executive;
      • (b) a person representative of patients in an area other than that of the second Health Board; and
      • (c) a person representative of the area medical committee which does not represent practitioners in the area of the second Health Board;
    • ...
    • “CCT” means a Certificate of Completion of Training awarded under section 34L(1) of the Medical Act 1983
    • including any such certificate awarded in pursuance of the competent authority functions of the General Medical Council specified in section 49B and...

    To continue reading

    Request your trial

    VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT